Geron Corp (NASDAQ:GERN) price on current trading day, fall -1.73% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $1.70.
A look at the stock’s price movement, the close in the last trading session was $1.73, moving within a range at $1.68 and $1.75. The beta value (5-Year monthly) was 0.532. Turning to its 52-week performance, $5.34 and $1.46 were the 52-week high and 52-week low respectively. Overall, GERN moved -35.36% over the past month.
Geron Corp’s market cap currently stands at around $1.08 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-25.
Analysts have a consensus estimate of 49.88M for the company’s revenue for the quarter, with a low and high estimate of 46.96M and 54.3M respectively. The average forecast suggests up to a 16,309.12% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 235.46M, representing a 205.82% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that GERN is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
5 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 4 recommend GERN as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
GERN’s current price about -8.18% and -32.18% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 33.64, while 7-day volatility ratio is 6.88% and 8.23% in the 30-day chart. Further, Geron Corp (GERN) has a beta value of 0.62, and an average true range (ATR) of 0.15. Analysts have given the company’s stock an average 52-week price target of $5.5, forecast between a low of $4 and high of $8. Looking at the price targets, the low is -135.29% off current price level while to achieve the yearly target high, price needs to move -370.59%. Nonetheless, investors will most likely welcome a -223.53% jump to $5.5 which is the analysts’ median price.
If we refocus on Geron Corp (NASDAQ:GERN), historical trading data shows that trading volumes averaged 13.3 over the past 10 days and 15.45 million over the past 3 months. The company’s latest data on shares outstanding shows there are 606.39 million shares.
The 6.13% of Geron Corp’s shares are in the hands of company insiders while institutional holders own 71.74% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 58.41 million on 2025-02-28, giving us a short ratio of 3.32. The data shows that as of 2025-02-28 short interest in Geron Corp (GERN) stood at 922.0000000000001 of shares outstanding, with shares short falling to 74.57 million registered in 2025-01-31. Current price change has pushed the stock -51.98% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the GERN stock continues to rise going into the next quarter.
